John Glenn is CFO at IRADIMED CORP (IRMD). They have made 6 open-market trades across 3 companies since 2006, most recently 2026-06-20.
CIK 0001253497
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IRMD | 11,937 | $1.1M |
| THRM | 17,786 | $517K |
| EKSO | 35,130 | $399K |
| CTEC | 8,000 | — |
| SLTM | 12,936 | — |
| Total | $2.0M |
Shares reported on the most recent Form 4, priced at the 2026-06-23 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IRMD | SELL | 2025-12-11 | 2025-12-12 | $97.29 | $2.9M | +0.2% | +1.1% | +2.6% |
| IRMD | SELL | 2025-11-10 | 2025-11-12 | $84.51 | $1.8M | +5.6% | +12.5% | +22.9% |
| IRMD | SELL | 2024-12-02 | 2024-12-02 | $54.18 | $135K | +1.8% | +2.8% | -0.3% |
| EKSO | SELL | 2022-03-22 | 2022-03-28 | $2.82 | $10K | -5.9% | -14.9% | -38.5% |
| EKSO | SELL | 2019-05-31 | 2019-06-19 | $1.37 | $14K | +0.0% | -4.3% | -56.7% |
| CTEC | SELL | 2006-11-15 | 2006-11-17 | $17.63 | $88K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.